Marieke van Son

79 FOCAL SALVAGE TREATMENT: A NARRATIVE REVIEW 44. Afshar-Oromieh, A.; Zechmann, C.M.; Malcher, A.; Eder, M.; Eisenhut, M.; Lin- hart, H.G.; Holland-Letz, T.; Hadaschik, B.A.; Giesel, F.L.; Debus, J., et al. Com- parison of pet imaging with a (68) ga-labelled psma ligand and (18)f-cho- line-based pet/ct for the diagnosis of re- current prostate cancer. European jour- nal of nuclear medicine and molecular imaging 2014, 41, 11-20; DOI: 10.1007/ s00259-013-2525-5. 45. Afshar-Oromieh, A.; Malcher, A.; Eder, M.; Eisenhut, M.; Linhart, H.G.; Ha- daschik, B.A.; Holland-Letz, T.; Giesel, F.L.; Kratochwil, C.; Haufe, S., et al. Pet imaging with a [68ga]gallium-labelled psma ligand for the diagnosis of pros- tate cancer: Biodistribution in humans and first evaluation of tumor lesions. Eu- ropean journal of nuclear medicine and molecular imaging 2013, 40, 486-495; DOI: 10.1007/s00259-012-2298-2. 46. Perera, M.; Murphy, D.; Lawrentschuk, N. Prostate-specific membrane antigen positron emission tomography/comput- ed tomography in locally advanced, re- current, and metastatic prostate cancer. JAMA oncology 2018, 4, 748-749; DOI: 10.1001/jamaoncol.2017.0287. 47. Zacho, H.D.; Nielsen, J.B.; Afshar-Oro- mieh, A.; Haberkorn, U.; deSouza, N.; De Paepe, K.; Dettmann, K.; Langkilde, N.C.; Haarmark, C.; Fisker, R.V., et al. Prospec- tive comparison of (68)ga-psma pet/ct, (18)f-sodium fluoride pet/ct and diffu- sion weighted-mri at for the detection of bone metastases in biochemically recurrent prostate cancer. European journal of nuclear medicine and molec- ular imaging 2018; DOI: 10.1007/s00259- 018-4058-4. 48. Kanthabalan, A.; Shah, T.; Arya, M.; Punwani, S.; Bomanji, J.; Haroon, A.; Illing, R.O.; Latifoltojar, A.; Freeman, A.; Jameson, C., et al. The forecast study - focal recurrent assessment and salvage treatment for radiorecurrent prostate cancer. Contemporary clinical trials 2015, 44, 175-186; DOI: 10.1016/j. cct.2015.07.004. 49. Futterer, J.J.; Briganti, A.; De Visschere, P.; Emberton, M.; Giannarini, G.; Kirkham, A.; Taneja, S.S.; Thoeny, H.; Villeirs, G.; Villers, A. Can clinically significant pros- tate cancer be detected with multipara- metric magnetic resonance imaging? A systematic review of the literature. Eur Urol 2015, 68, 1045-1053; DOI: 10.1016/j. eururo.2015.01.013. 50. Ahmed, H.U.; El-Shater Bosaily, A.; Brown, L.C.; Gabe, R.; Kaplan, R.; Parmar, M.K.; Collaco-Moraes, Y.; Ward, K.; Hind- ley, R.G.; Freeman, A., et al. Diagnostic accuracy of multi-parametric mri and trus biopsy in prostate cancer (promis): A paired validating confirmatory study. Lancet 2017, 389, 815-822; DOI: 10.1016/ S0140-6736(16)32401-1. 51. Le, J.D.; Tan, N.; Shkolyar, E.; Lu, D.Y.; Kwan, L.; Marks, L.S.; Huang, J.; Margo- lis, D.J.; Raman, S.S.; Reiter, R.E. Multi- focality and prostate cancer detection by multiparametric magnetic resonance imaging: Correlation with whole-mount histopathology. Eur Urol 2015, 67, 569- 576; DOI: 10.1016/j.eururo.2014.08.079. 52. Haider, M.A.; Chung, P.; Sweet, J.; Toi, A.; Jhaveri, K.; Menard, C.; Warde, P.; Trachtenberg, J.; Lockwood, G.; Milos- evic, M. Dynamic contrast-enhanced magnetic resonance imaging for local- ization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70, 425-430; DOI: 10.1016/j.ijrobp.2007.06.029. 53. Roy, C.; Foudi, F.; Charton, J.; Jung, M.; Lang, H.; Saussine, C.; Jacqmin, D. Comparative sensitivities of function- al mri sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. AJR. American journal of roentgenology 2013, 200, W361-368; DOI: 10.2214/AJR.12.9106. 4